新型自粘性硬脑膜替代物在犬幕上硬脑膜切开模型中的安全性与有效性
该研究在犬幕上硬脑膜切开模型中评估新型聚乙二醇涂层胶原垫(PCC)作为硬脑膜替代物及密封剂的安全性与有效性,安全性研究共24只动物,有效性研究共36只动物,结果显示PCC作为硬脑膜替代物安全、作为硬脑膜密封剂有效,其与纤维蛋白原和凝血酶涂层胶原垫(FTC)在爆破压力测试中各时间点及总体均无显著差异(13.9 vs 12.3 mm Hg,每组n=18,P=.46)。
要点
- PCC作为硬脑膜替代物在犬模型中未观察到异常临床体征或组织病理学改变。
- MRI未见脑受压、脑脊液漏、出血或脑积水的持续征象。
- PCC与FTC作为密封剂的爆破压力各时间点及总体均无显著差异(P=.46)。
核心结论
- PCC作为硬脑膜替代物是安全的,作为硬脑膜密封剂是有效的。
- 新型自粘性聚乙二醇基密封剂与胶原垫的组合可能为硬脑膜成形术的进展提供独特益处。
研究设计与样本
- 采用犬幕上硬脑膜切开手术模型研究PCC的安全性和有效性。
- 安全性研究:4只动物双侧分别接受DGX或PCC处理,分别于1、8或16周恢复,共24只动物。
- 有效性研究:9只动物单侧接受FTC或PCC处理,术中或术后14天进行爆破压力测试,共36只动物。
主要发现
- 安全性研究中,DGX或PCC处理动物在体格和神经系统检查、临床病理学、脑脊液分析或组织病理学方面均未观察到异常临床体征或改变。
- MRI未见脑受压、脑脊液漏、出血或脑积水的持续征象。
- 有效性研究中,FTC与PCC在各时间点及总体均无显著差异(13.9 vs 12.3 mm Hg,每组n=18,P=.46)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebrospinal fluid (CSF) leaks increase postoperative risk for complication, likelihood of reoperation, and costs. OBJECTIVE: To investigate a novel, self-adhering polyethylene glycol-coated collagen pad (PCC) as a dural substitute relative to Duragen XS (DGX; Integra LifeSciences Corporation, Plainsboro, New Jersey) and as a dural sealant relative to Tachosil (Takeda Austria GmbH, Linz, Austria), a fibrinogen and thrombin-coated collagen pad (FTC). METHODS: A canine supratentorial durotomy surgical model was used to investigate the safety and efficacy of PCC. For safety, 4 animals were bilaterally treated with DGX or PCC and recovered for 1, 8, or 16 wk; total 24 animals. Each animal underwent physical and neurological examinations weekly and 16-wk animals underwent a magnetic resonance imaging (MRI) examination at each time point. For efficacy, 9 animals were unilaterally treated with FTC or PCC and underwent a burst pressure test intraoperatively or 14 d postoperatively; total 36 animals. RESULTS: In the safety study, no abnormal clinical signs or changes were noted on physical and neurological examinations, or in clinical pathology, CSF analysis or histopathology of DGX or PCC-treated animals. No consistent signs of cerebral compression, CSF leak, hemorrhage, or hydrocephalus were noted on MRI. In the efficacy study, no significant difference was found between FTC and PCC at each time point or overall (13.9 vs 12.3 mm Hg, n = 18 per group, P = .46). CONCLUSION: PCC is safe for use as a dural substitute and effective as a dural sealant. The novel, self-adhering combination of a polyethylene glycol-based sealant and a collagen pad may offer unique benefits to the advancement of duraplasty.
引用
- Lewis KM, Sweet J, Wilson ST, et al. Safety and Efficacy of a Novel, Self-Adhering Dural Substitute in a Canine Supratentorial Durotomy Model. Neurosurgery. 2018. PMID: 28575349. doi:10.1093/neuros/nyx216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。